Author:
Stojanova Jana,Luque Sonia
Reference166 articles.
1. Dasgupta A (2012) Introduction to therapeutic drug monitoring. Frequently and less frequently monitored drugs. In: Therapeutic drug monitoring, 1st edn. Elsevier, New York, p 1–29
2. Walson PD (1998) Therapeutic drug monitoring in special populations. Clin Chem 44:415–419
3. Roberts JA, Abdul-Aziz MH, Lipman J et al (2014) Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions. Lancet Infect Dis 14:498–509. doi: 10.1016/S1473-3099(14)70036-2
4. Fish DN, Piscitelli SC, Danziger LH (1995) Development of resistance during antimicrobial therapy: a review of antibiotic classes and patient characteristics in 173 studies. Pharmacotherapy 15:279–291
5. Pea F, Cojutti P, Sbrojavacca R et al (2011) TDM-guided therapy with daptomycin and meropenem in a morbidly obese, critically ill patient. Ann Pharmacother 45:e37. doi: 10.1345/aph.1P745
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献